- Home
- ARCT vs TMCI Comparison
ARCT vs TMCI Comparison
Compare ARCT & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARCT | TMCI |
|---|---|---|
| Founded | 2013 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.9M | 292.0M |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ARCT | TMCI |
|---|---|---|
| Price | $10.29 | $3.95 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 5 |
| Target Price | ★ $23.80 | $5.50 |
| AVG Volume (30 Days) | ★ 636.5K | 190.1K |
| Earning Date | 11-05-2026 | 11-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.00 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $82,031,000.00 | ★ $212,690,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $54.47 | $6.88 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 1.59 |
| 52 Week Low | $5.50 | $1.17 |
| 52 Week High | $17.96 | $5.25 |
Technical Indicators
Market Signals| Indicator | ARCT | TMCI |
|---|---|---|
| Relative Strength Index (RSI) | 45.33 | 40.91 |
| Support Level | $6.53 | $3.82 |
| Resistance Level | $12.44 | $4.77 |
| Average True Range (ATR) | 1.07 | 0.38 |
| MACD | -0.02 | -0.03 |
| Stochastic Oscillator | 37.25 | 25.96 |
Price Performance
Historical ComparisonAbout ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.